1. Hyperprolactinemia in clinical non-functional pituitary macroadenomas
- Author
-
Weichao Ma, Peizhi Zhou, Zeming Wang, Liang Lyu, Senlin Yin, Yu Hu, Shu Jiang, Cheng Chen, Yang Yu, and Yong Jiang
- Subjects
medicine.medical_specialty ,business.industry ,Medical record ,Urology ,Retrospective cohort study ,General Medicine ,Hypopituitarism ,Odds ratio ,medicine.disease ,Prolactin ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Cohort ,medicine ,Endocrine system ,030212 general & internal medicine ,business ,Pathological ,hormones, hormone substitutes, and hormone antagonists - Abstract
Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-functional pituitary adenomas (NFPAs). However, the mechanism involved in hyperprolactinemia in NFPA is not fully illustrated. The current study aims to investigate predictors for hyperprolactinemia in NFPA via analyzing relevant clinical features. Thus, in this study, a cohort of 214 cases with integrated medical records was retrospectively analyzed concerning clinical, pathological, and endocrinological studies before and after surgery.Hyperprolactinemia happened in 93 cases (43.5%). Women (adjust odds ratio [OR] = 3.093; P < .01), age of patients (adjust OR = 0.951; P < .01), and serum free tetraiodothyronine (FT4) level (adjust OR = 0.882; P = .02) were independent predictors for developing preoperative hyperprolactinemia. Tumor size and hypopituitarism had no impact on hyperprolactinemia. During a median follow-up of 43.5 (range, 22-80) months, 83.9% patients with preoperative hyperprolactinemia experienced prolactin (PRL) normalization. Preoperative PRL level (adjusted OR = 1.741, P = .03) was the exclusive predictor for PRL normalization after adjusting for tumor volume, preoperative serum FT4 concentration, and postoperative residual. The PRL normalization rate of patients with lower PRL level (
- Published
- 2020
- Full Text
- View/download PDF